Shanghai Pharma - M&A Summary and Business Overview

Life ScienceCompany

Shanghai Pharma M&A Summary

Shanghai Pharma has acquired 1 company.

Shanghai Pharma’s largest acquisition to date was in 2017, when it acquired Cardinal Health - China Business for $1.2B. The Company’s most targeted sectors include healthcare services (100%).

Shanghai Pharma Business Overview

Where is Shanghai Pharma headquartered?

Shanghai Pharma is headquartered in Shanghai, China.

What is Shanghai Pharma’s revenue?

Shanghai Pharma disclosed revenue of 260,295M CNY for 2023 and 231,981M CNY for 2022.

How many employees does Shanghai Pharma have?

Shanghai Pharma has 49,234 employees.

What sector is Shanghai Pharma in?

Shanghai Pharma is a life science company.

When was Shanghai Pharma founded?

Shanghai Pharma was founded in 1994.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Shanghai Pharma

Shanghai Pharmaceuticals Holding Co. Ltd.

Shanghai Pharmaceutical Building No. 200 Taicang Road,
Shanghai, 200020
China,
+86 21 6373 0908
www.sphchina.com

Shanghai Pharma is a pharmaceutical group with business extending across the entire value chain. The company is engaged in the research and development, manufacturing, distribution, and retail of pharmaceutical products and innovative healthcare services. Its revenue and profit sustained growth at CAGR of 15.4% and 11.7% from 2011 to 2016 reaching RMB120.8 billion and RMB3.8 billion respectively. Shanghai Pharma was founded in 1994 and is based in Shanghai, China.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
vol $1.2B $1.2B
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Cardinal Health, Inc. - China Business 2017-11-14 1.2B USD Divestiture
, China
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Healthcare Services 1 (100%) 1.2B (100%) - -
Total 1 $1.2B - -

By Geo

State/Country Buy Value Sell Value
China 1 1.2B - -
Total 1 $1.2B - -

Deal Values

buy # Total
> $1B 1 $1.2B
TOTAL $1.2B
Largest Cardinal Health, Inc. - China Business
$1.2B (2017-11-14)

M&A Connections

Deals
Acquired from
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Shanghai Pharma

Life Science Companies , China Companies